Indeed, numerous factors contribute to this relationship, such as the duration of diabetes, HbA1c, background treatment, complications, accompanying diseases, β‐cell function, the timing and duration of insulin therapy, and the stage of DR. This evidence concerns the gene INS and diabetes mellitus.